Mergers and acquisitions are occurring in response to a change environment where organizations are trying to deliver a more comprehensive service, explained Dan Mendelson, MPP, founder, Avalere Health.
Mergers and acquisitions are occurring in response to a change environment where organizations are trying to deliver a more comprehensive service, explained Dan Mendelson, MPP, founder, Avalere Health.
Transcript
How are mergers and acquisitions affecting the market, and do you think this is where the future of healthcare is headed?
Mergers and acquisitions really stem out of this change environment, and you see really the larger organizations—CVS, Aetna, and the like—responding to this change environment. They’re trying to figure out how do we deliver a more comprehensive service offering that really accomplishes what government and other major payers want us to deliver. So, to me this is really fundamental for retail pharmacy. Now, retail pharmacy has not been a bright spot economically, really, for anyone operating it, and that’s not secret.
So, reinventing the pharmacy and kind of reimagining what can be done in that context to engage patients is really important, and I think that we are likely to see a lot of M&A activity that is really focused around that so the idea of a combination of health plan and a drug store, for example, kind of speaks to that.
Then, we have some mergers and acquisitions that are just about creating scale, just getting larger. And if you get larger, you can reduce your cost basis and be a more effective player in the marketplace. So, we will continue to see that both in the pharmacy area, as well as in the health plan area, as well as in the provider area. A lot of activity, we expect it really to continue. In fact, it might even intensify over time as the demands of the payers become a bit more strenuous.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More